Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada
· Delayed Price · Currency is CAD 0.1600
+0.0100 (6.67%)
Apr 1, 2025, 3:59 PM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 16.55 million as of April 1, 2025. Its market cap has increased by 12.04% in one year.
Market Cap
16.55M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 16.55M, an increase of 149.29%. That is a compound annual growth rate of 32.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 15.52M | -39.94% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 1.91B |
| dentalcorp Holdings | 1.62B |
| Sienna Senior Living | 1.50B |
| WELL Health Technologies | 1.25B |
| Extendicare | 1.09B |
| Curaleaf Holdings | 1.08B |
| Trulieve Cannabis | 1.05B |
| Cronos Group | 979.28M |